SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001735276-24-000095
Filing Date
2024-10-03
Accepted
2024-10-03 16:08:51
Documents
2
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 1622
2 EDGAR SUPPORTING DOCUMENT hesslein_20241001poa.txt EX-24 4096
  Complete submission text file 0001735276-24-000095.txt   7328
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FOUNDATION MEDICINE, INC. ONE KENDALL SQUARE, SUITE B3501 CAMBRIDGE MA 02139
Business Address
Hesslein Robert W. (Reporting) CIK: 0001585018 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36407 | Film No.: 241351541